Eight years after the market release of VANGUARD crLyme, a first-of-its-kind vaccine designed to prevent Lyme disease in dogs, the Marconi laboratory in the Department of Microbiology and Immunology of the Virginia Commonwealth University School of Medicine is on the precipice of completing another medical innovation.
